205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.98%
Revenue growth under 50% of INTC's 16.24%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
11.21%
Gross profit growth under 50% of INTC's 26.90%. Michael Burry would be concerned about a severe competitive disadvantage.
25.22%
EBIT growth below 50% of INTC's 58.81%. Michael Burry would suspect deeper competitive or cost structure issues.
25.22%
Operating income growth under 50% of INTC's 58.81%. Michael Burry would be concerned about deeper cost or sales issues.
27.21%
Net income growth at 50-75% of INTC's 40.14%. Martin Whitman would question fundamental disadvantages in expenses or demand.
30.95%
EPS growth at 75-90% of INTC's 40.91%. Bill Ackman would push for improved profitability or share repurchases to catch up.
28.57%
Diluted EPS growth at 75-90% of INTC's 36.36%. Bill Ackman would expect further improvements in net income or share count reduction.
-1.39%
Share reduction while INTC is at 0.48%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.43%
Reduced diluted shares while INTC is at 0.85%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.53%
Dividend growth above 1.5x INTC's 0.28%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
70.49%
OCF growth 1.25-1.5x INTC's 60.70%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
90.47%
FCF growth 50-75% of INTC's 145.48%. Martin Whitman would see if structural disadvantages exist in generating free cash.
59.81%
10Y revenue/share CAGR at 50-75% of INTC's 83.68%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
96.53%
5Y revenue/share CAGR 1.25-1.5x INTC's 76.64%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
37.60%
3Y revenue/share CAGR 1.25-1.5x INTC's 30.09%. Bruce Berkowitz might see better product or regional expansions than the competitor.
205.28%
10Y OCF/share CAGR above 1.5x INTC's 81.32%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
226.83%
5Y OCF/share CAGR above 1.5x INTC's 84.96%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
98.43%
3Y OCF/share CAGR above 1.5x INTC's 33.82%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
-50.56%
Negative 10Y net income/share CAGR while INTC is at 27.49%. Joel Greenblatt sees a major red flag in long-term profit erosion.
397.85%
5Y net income/share CAGR above 1.5x INTC's 197.26%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
68.28%
3Y net income/share CAGR above 1.5x INTC's 2.63%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
92.20%
10Y equity/share CAGR at 50-75% of INTC's 129.76%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
21.10%
5Y equity/share CAGR at 50-75% of INTC's 31.90%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
5.44%
Below 50% of INTC's 16.96%. Michael Burry suspects a serious short-term disadvantage in building book value.
288.56%
Below 50% of INTC's 1402.30%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
278.60%
5Y dividend/share CAGR at 50-75% of INTC's 462.45%. Martin Whitman might see a lagging policy in mid-term shareholder returns.
286.61%
3Y dividend/share CAGR above 1.5x INTC's 183.62%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
6.64%
AR growth is negative/stable vs. INTC's 15.88%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
1.83%
We show growth while INTC is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-2.11%
Negative asset growth while INTC invests at 5.46%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.74%
We have a declining book value while INTC shows 2.54%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-1.63%
Our R&D shrinks while INTC invests at 12.42%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
1.18%
SG&A declining or stable vs. INTC's 7.32%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.